Statistical Parametric Mapping reveals ligand and region-specific activation of G-proteins by CB1 receptors and non-CB1 sites in the 3D reconstructed mouse brain

NeuroImage

Volumn 52, Issue 4, 2010, Pages 1243-1251

  Nguyen, P T ^a   Selley, D E ^a   Sim Selley, L J ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2,3 DIHYDRO 5 METHYL 3 (MORPHOLINOMETHYL) 6 (1 NAPHTHOYL)PYRROLO[1,2,3 DE][1,4]BENZOXAZINE; 4 (1,1 DIMETHYLHEPTYL) 1',2',3',4',5',6' HEXAHYDRO 2,3' DIHYDROXY 6' (3 HYDROXYPROPYL)BIPHENYL; CANNABINOID 1 RECEPTOR; GUANINE NUCLEOTIDE BINDING PROTEIN; GUANINE NUCLEOTIDE BINDING PROTEIN GAMMA SUBUNIT; METHANANDAMIDE; RIMONABANT; SULFUR 35;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; AUTORADIOGRAPHY; BASAL GANGLION; BINDING SITE; BRAIN CORTEX; BRAIN MAPPING; BRAIN STEM; CEREBELLUM; CONTROLLED STUDY; HIPPOCAMPUS; HYPOTHALAMUS; IMAGE RECONSTRUCTION; MALE; MOUSE; NEUROIMAGING; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; STATISTICAL ANALYSIS; THREE DIMENSIONAL IMAGING;

ANIMALS; BRAIN; DATA INTERPRETATION, STATISTICAL; GTP-BINDING PROTEINS; IMAGING, THREE-DIMENSIONAL; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; RECEPTOR, CANNABINOID, CB1; TISSUE DISTRIBUTION;

EID: 77954951850     PISSN: 10538119     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroimage.2010.04.259     Document Type: Article

References (53)

1. Ashburner J.K.J.F. Nonlinear spatial normalization using basis functions. Hum. Brain Mapp. 1999, 7:254-266.
2. Aston-Jones G., Rajkowski J., Cohen J. Role of locus coeruleus in attention and behavioral flexibility. Biol. Psychiatry 1999, 46:1309-1320.
3. Breivogel C.S., Childers S.R. Cannabinoid agonist signal transduction in rat brain: comparison of cannabinoid agonists in receptor binding, G-protein activation, and adenylyl cyclase inhibition. J. Pharmacol. Exp. Ther. 2000, 295:328-336.
4. Breivogel C.S., Childers S.R., Deadwyler S.A., Hampson R.E., Vogt L.J., Sim-Selley L.J. Chronic delta9-tetrahydrocannabinol treatment produces a time-dependent loss of cannabinoid receptors and cannabinoid receptor-activated G proteins in rat brain. J. Neurochem. 1999, 73:2447-2459.
5. Breivogel C.S., Griffin G., Di Marzo V., Martin B.R. Evidence for a new G protein-coupled cannabinoid receptor in mouse brain. Mol. Pharmacol. 2001, 60:155-163.
6. Breivogel C.S., Selley D.E., Childers S.R. Cannabinoid receptor agonist efficacy for stimulating [35S]GTPgammaS binding to rat cerebellar membranes correlates with agonist-induced decreases in GDP affinity. J. Biol. Chem. 1998, 273:16865-16873.
7. Bremner J.D., Krystal J.H., Southwick S.M., Charney D.S. Noradrenergic mechanisms in stress and anxiety: I. Preclinical studies. Synapse 1996, 23:28-38.
8. Devane W.A., Dysarz F.A., Johnson M.R., Melvin L.S., Howlett A.C. Determination and characterization of a cannabinoid receptor in rat brain. Mol. Pharmacol. 1988, 34:605-613.
9. Di Marzo V., Breivogel C.S., Tao Q., Bridgen D.T., Razdan R.K., Zimmer A.M., Zimmer A., Martin B.R. Levels, metabolism, and pharmacological activity of anandamide in CB(1) cannabinoid receptor knockout mice: evidence for non-CB(1), non-CB(2) receptor-mediated actions of anandamide in mouse brain. J. Neurochem. 2000, 75:2434-2444.
10. Dubois A., Herard A.S., Flandin G., Duchesnay E., Besret L., Frouin V., Hantraye P., Bonvento G., Delzescaux T. Quantitative validation of voxel-wise statistical analyses of autoradiographic rat brain volumes: application to unilateral visual stimulation. Neuroimage 2008, 40:482-494.
11. Foote S.L., Bloom F.E., Aston-Jones G. Nucleus locus ceruleus: new evidence of anatomical and physiological specificity. Physiol. Rev. 1983, 63:844-914.
12. Franklin K., Paxinos G. The Mouse Brain in Stereotaxic Coordinates 2008, Elsevier, New York, NY. 3rd ed.
13. Friston K.J., Ashburner J., Poline J.B., Frith C.D., Heather J.D., Frackowiak R.S. Spatial registration and normalization of images. Hum. Brain Mapp. 1995, 2:165-168.
14. Friston K.J., Frith C.D., Liddle P.F., Dolan R.J., Lammertsma A.A., Frackowiak R.S. The relationship between global and local changes in PET scans. J. Cereb. Blood Flow Metab. 1990, 10:458-466.
15. Friston K.J., Frith C.D., Liddle P.F., Frackowiak R.S. Comparing functional (PET) images: the assessment of significant change. J. Cereb. Blood Flow Metab. 1991, 11:690-699.
16. Friston K.J., Holmes A., Poline J.B., Price C.J., Frith C.D. Detecting activations in PET and fMRI: levels of inference and power. Neuroimage 1996, 4:223-235.
17. Friston K.J., Holmes A., Worsley K.J., Poline J.B., Frith C.D., Frackowiak R.S. Statistical parametric maps in functional imaging: a general linear approach. Hum. Brain Mapp. 1995, 2:189-210.
18. Friston K.J., Worsley K.J., Frackowiak R.S., Mazziotta J.C., Evans A.C. Assessing the significance of focal activations using their spatial extent. Hum. Brain Mapp. 1994, 1:214-220.
19. Glass M., Northup J.K. Agonist selective regulation of G proteins by cannabinoid CB(1) and CB(2) receptors. Mol. Pharmacol. 1999, 56:1362-1369.
20. Govaerts S.J., Hermans E., Lambert D.M. Comparison of cannabinoid ligands affinities and efficacies in murine tissues and in transfected cells expressing human recombinant cannabinoid receptors. Eur. J. Pharm. Sci. 2004, 23:233-243.
21. Hajos N., Ledent C., Freund T.F. Novel cannabinoid-sensitive receptor mediates inhibition of glutamatergic synaptic transmission in the hippocampus. Neuroscience 2001, 106:1-4.
22. Herkenham M., Lynn A.B., Johnson M.R., Melvin L.S., de Costa B.R., Rice K.C. Characterization and localization of cannabinoid receptors in rat brain: a quantitative in vitro autoradiographic study. J. Neurosci. 1991, 11:563-583.
23. Hoffman A.F., Macgill A.M., Smith D., Oz M., Lupica C.R. Species and strain differences in the expression of a novel glutamate-modulating cannabinoid receptor in the rodent hippocampus. Eur. J. Neurosci. 2005, 22:2387-2391.
24. Hollister L.E. Health aspects of cannabis. Pharmacol. Rev. 1986, 38:1-20.
25. Holschneider D.P., Yang J., Sadler T.R., Nguyen P.T., Givrad T.K., Maarek J.M. Mapping cerebral blood flow changes during auditory-cued conditioned fear in the nontethered, nonrestrained rat. Neuroimage 2006, 29:1344-1358.
26. Howlett A.C., Barth F., Bonner T.I., Cabral G., Casellas P., Devane W.A., Felder C.C., Herkenham M., Mackie K., Martin B.R., Mechoulam R., Pertwee R.G. International Union of Pharmacology. XXVII. Classification of cannabinoid receptors. Pharmacol. Rev. 2002, 54:161-202.
27. Mackie K., Stella N. Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. 2006, 8:E298-E306.
28. Matsuda L.A., Lolait S.J., Brownstein M.J., Young A.C., Bonner T.I. Structure of a cannabinoid receptor and functional expression of the cloned cDNA. Nature 1990, 346:561-564.
29. Mukhopadhyay S., McIntosh H.H., Houston D.B., Howlett A.C. The CB(1) cannabinoid receptor juxtamembrane C-terminal peptide confers activation to specific G proteins in brain. Mol. Pharmacol. 2000, 57:162-170.
30. Munro S., Thomas K.L., Abu-Shaar M. Molecular characterization of a peripheral receptor for cannabinoids. Nature 1993, 365:61-65.
31. National Research Council, 1996. Guide for the Care and Use of Laboratory Animals. National Academy Press: Washington, DC.
32. Nguyen P.T., Holschneider D.P., Maarek J.M., Yang J., Mandelkern M.A. Statistical Parametric Mapping applied to an autoradiographic study of cerebral activation during treadmill walking in rats. Neuroimage 2004, 23:252-259.
33. Oropeza V.C., Mackie K., Van Bockstaele E.J. Cannabinoid receptors are localized to noradrenergic axon terminals in the rat frontal cortex. Brain Res. 2007, 1127:36-44.
34. Oropeza V.C., Page M.E., Van Bockstaele E.J. Systemic administration of WIN55,212-2 increases norepinephrine release in the rat frontal cortex. Brain Res. 2005, 1046:45-54.
35. Page M.E., Oropeza V.C., Van Bockstaele E.J. Local administration of a cannabinoid agonist alters norepinephrine efflux in the rat frontal cortex. Neurosci. Lett. 2008, 431:1-5.
36. Pistis M., Perra S., Pillolla G., Melis M., Gessa G.L., Muntoni A.L. Cannabinoids modulate neuronal firing in the rat basolateral amygdala: evidence for CB1- and non-CB1-mediated actions. Neuropharmacology 2004, 46:115-125.
37. Prather P.L., Martin N.A., Breivogel C.S., Childers S.R. Activation of cannabinoid receptors in rat brain by WIN55212-2 produces coupling to multiple G protein alpha-subunits with different potencies. Mol. Pharmacol. 2000, 57:1000-1010.
38. Ross R.A. The enigmatic pharmacology of GPR55. Trends Pharmacol. Sci. 2009, 30:156-163.
39. Schlicker E., Kathmann M. Modulation of transmitter release via presynaptic cannabinoid receptors. Trends Pharmacol. Sci. 2001, 22:565-572.
40. Schlicker E., Timm J., Zentner J., Gothert M. Cannabinoid CB1 receptor-mediated inhibition of noradrenaline release in the human and guinea-pig hippocampus. Naunyn. Schmiedebergs Arch. Pharmacol. 1997, 356:583-589.
41. Sim-Selley L.J. Regulation of cannabinoid CB1 receptors in the central nervous system by chronic cannabinoids. Crit. Rev. Neurobiol. 2003, 15:91-119.
42. Sim-Selley L.J., Brunk L.K., Selley D.E. Inhibitory effects of SR141716A on G-protein activation in rat brain. Eur. J. Pharmacol. 2001, 414:135-143.
43. Sim-Selley L.J., Childers S.R. Neuroanatomical localization of receptor-activated G proteins in brain. Meth. Enzymol. 2002, 344:42-58.
44. Sim-Selley L.J., Schechter N.S., Rorrer W.K., Dalton G.D., Hernandez J., Martin B.R., Selley D.E. Prolonged recovery rate of CB1 receptor adaptation after cessation of long-term cannabinoid administration. Mol. Pharmacol. 2006, 70:986-996.
45. Sim L.J., Hampson R.E., Deadwyler S.A., Childers S.R. Effects of chronic treatment with delta9-tetrahydrocannabinol on cannabinoid-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 1996, 16:8057-8066.
46. Sim L.J., Selley D.E., Childers S.R. In vitro autoradiography of receptor-activated G proteins in rat brain by agonist-stimulated guanylyl 5′-[gamma-[35S]thio]-triphosphate binding. Proc. Natl. Acad. Sci. U.S.A. 1995, 92:7242-7246.
47. Sim L.J., Selley D.E., Dworkin S.I., Childers S.R. Effects of chronic morphine administration on mu opioid receptor-stimulated [35S]GTPgammaS autoradiography in rat brain. J. Neurosci. 1996, 16:2684-2692.
48. Soto-Montenegro M.L., Vaquero J.J., Pascau J., Gispert J.D., Garcia-Barreno P., Desco M. Detection of visual activation in the rat brain using 2-deoxy-2-[(18)F]fluoro-d: -glucose and Statistical Parametric Mapping (SPM). Mol. Imaging Biol. 2008.
49. Thévenaz P., Ruttimann U.E., Unser M. A pyramid approach to subpixel registration based on intensity. IEEE Trans. Image Proc. 1998, 7:27-41.
50. Tsou K., Brown S., Sanudo-Pena M.C., Mackie K., Walker J.M. Immunohistochemical distribution of cannabinoid CB1 receptors in the rat central nervous system. Neuroscience 1998, 83:393-411.
51. Van Sickle M.D., Duncan M., Kingsley P.J., Mouihate A., Urbani P., Mackie K., Stella N., Makriyannis A., Piomelli D., Davison J.S., Marnett L.J., Di Marzo V., Pittman Q.J., Patel K.D., Sharkey K.A. Identification and functional characterization of brainstem cannabinoid CB2 receptors. Science 2005, 310:329-332.
52. Worsley K.J., Evans A.C., Marrett S., Neelin P. A three-dimensional statistical analysis for CBF activation studies in human brain. J. Cereb. Blood Flow Metab. 1992, 12:900-918.
53. Yang J., Sadler T.R., Givrad T.K., Maarek J.M., Holschneider D.P. Changes in brain functional activation during resting and locomotor states after unilateral nigrostriatal damage in rats. Neuroimage 2007, 36:755-773.